MD Neurochir SRL
MD Neurochir reported total assets of 525,416 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
By total assets for 2025, MD Neurochir ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of MD Neurochir shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MD Neurochir's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
MD Neurochir's financial analysis
- Solvency48.1%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MD Neurochir
MD Neurochir's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1006.566.921
- VAT number
- BE1006566921
- Peppol
- Registered · 0208:1006566921 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Feb 2024
- Registered office
- 7110 La Louvière
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Medical specialists activities (NACE 86220)
MD Neurochir (SRL) has been based in La Louvière since 2024, active in: medical specialists activities. For 2025, it reports a net profit of 79,362 € and equity of 252,553 €; its revenue is not published. Its solvency stands at 48.1%, below the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MD Neurochir
Companies in the same business, of comparable size and area, outside its group.
- Dokter PETER BOMANS Medical specialists activities Mechelen · balance sheet 491,761 €
- Dr. J. Goossens, Anesthesist Medical specialists activities Lokeren · balance sheet €1.73m
- Jarta Medical specialists activities Lint · balance sheet 516,546 €
- Dr. Helena Devos Medical specialists activities Merelbeke-Melle · balance sheet 481,805 €
- Dr Milie Nwoye Gynecology Medical specialists activities Tervuren · balance sheet 512,618 €
- Dr. Heymans Julie Medical specialists activities Balen · balance sheet 540,185 €
- Docteur Pierre Defresne Medical specialists activities Tournai · balance sheet 510,306 €
- Naosu Medical specialists activities Lo-Reninge · balance sheet 544,137 €
Frequently asked questions about MD Neurochir
What is the revenue of MD Neurochir?
MD Neurochir files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MD Neurochir?
In Belgium, the VAT number is the company number prefixed with BE: BE1006566921 for MD Neurochir, if the company is VAT-registered. Its company number (CBE) is 1006.566.921.
Where is the registered office of MD Neurochir?
According to the CBE register, the registered office of MD Neurochir is in 7110 La Louvière.
What is the equity of MD Neurochir?
At the close of the 2025 financial year, the equity of MD Neurochir amounts to 252,553 €, a solvency of 48.1% of total assets.
Who manages MD Neurochir?
The register lists 1 active mandates at MD Neurochir. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is MD Neurochir within its sector?
By total assets for 2025, MD Neurochir ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of MD Neurochir
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →